| Form | Liquid |
|---|
| Host Species | Chimeric |
|---|
| Clonality | Monoclonal |
|---|
| Isotype | IgG1-kappa |
|---|
| Purity | >95% purity as determined by SDS-PAGE. |
|---|
| Purification | Protein A/G purified from cell culture supernatant. |
|---|
| Concentration | 1.82mg/ml |
|---|
| Endotoxin Level | Please contact the lab for this information. |
|---|
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
|---|
| Species Reactivity | General |
|---|
| Target | Phosphatidylserine |
|---|
| Storage Buffer | 0.01M PBS, pH 7.4. |
|---|
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
|---|
| Expression System | Mammalian Cells |
|---|
| Accession Number | 1446756-47-3 |
|---|
| Background | Bavituximab (Anti-Human Phosphatidylserine Recombinant Antibody) is a phosphatidylserine (PS)-targeting monoclonal antibody, suppresses tumor growth by targeting tumor vasculature and reactivating antitumor immunity. Bavituximab plus Paclitaxel and Carboplatin, have enhanced inhibition on non-small-cell lung cancer.<br>• Phosphatidylserine and the human brain., PMID:25933483<br/>• The distribution and function of phosphatidylserine in cellular membranes., PMID:20192774<br/>• Phosphatidylserine transport in cell life and death., PMID:37413778<br/>• Phosphatidylserine., PMID:10541030<br/>• Phosphatidylserine: A Novel Target for Ischemic Stroke Treatment., PMID:39456225<br/>• Phosphatidylserine for the Treatment of Pediatric Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis., PMID:33539192<br/>• Phosphatidylserine externalization as immune checkpoint in cancer., PMID:38573347<br/>• Phosphatidylserine: A comprehensive overview of synthesis, metabolism, and nutrition., PMID:39097133<br/>• Dynamics of phagocytosis mediated by phosphatidylserine., PMID:36281986<br/>• Flagging fusion: Phosphatidylserine signaling in cell-cell fusion., PMID:33581114<br/> |
|---|
| Alternative Names | Tarvacinch3 G4, CAS: 648904-28-3 |
|---|
| Note | For research use only. Not suitable for clinical or therapeutic use. |
|---|